Back to search

Institutional Repository of Vilnius University

Mezenchiminių kamieninių ląstelių sekretuojamų mitochondrijas turinčių ekstraląstelinių vezikulių poveikio doksorubicino sukeltai AC16 kardiomiocitų hipertrofijai vertinimas /

Abstract

dc:description

Cardiomyocyte hypertrophy is one of the major causes of heart disease, which is why innovative therapeutic strategies are being explored to protect these cells from damage and preserve their function. In laboratory settings, hypertrophy can be induced using chemical agents such as doxorubicin (DOX). To better mimic the natural cellular microenvironment, experiments can be conducted in three-dimensional (3D) cell cultures. One of the most recent approaches to mitigating hypertrophy-induced damage is the transfer of healthy mitochondria into damaged cells via mitochondrial content-containing extracellular vesicles (MitoEVs) secreted by mesenchymal stem cells (MSCs). The aim of this study was to identify DOX-induced hypertrophic changes in the AC16 cardiomyocyte cell line and to evaluate the effect of MitoEVs secreted by bone marrow MSCs (BM-MSCs) and menstrual blood-derived MSCs (Men-MSCs) on hypertrophy. This objective was achieved by first assessing the morphological and functional changes induced by DOX in AC16 cardiomyocytes, applying the same senescence-hypertrophy model on 3D scaffolds, comparing the MitoEVs secretion capacity of BM-MSCs and Men-MSCs, and finally evaluating the effect of MitoEVs on hypertrophy. Hypertrophy in AC16 cardiomyocytes was induced by incubating cells with 0.05 µM DOX. The 3D model was constructed using polyvinylidene fluoride (PVDF) and PVDF with graphene oxide (PVDF+GO) scaffolds. Morphological and functional cellular changes were assessed by evaluating cell and nuclear size, cell proliferation, cell cycle distribution, and β-galactosidase expression. Fluorescent dyes targeting mitochondrial and MitoEV surface markers were used to identify MitoEVs and analyze their uptake by the cells. Significant hypertrophic changes in AC16 cardiomyocytes included increased cell and nuclear size, G2 phase cell cycle arrest, decreased proliferation, and elevated β-galactosidase expression. Comparable changes were observed in cells cultured on PVDF and PVDF+GO scaffolds. BM-MSCs and Men-MSCs exhibited similar MitoEV secretion activity and transfer into AC16 cardiomyocytes; however, no significant protective effect was observed. These findings suggest a need to optimize the therapeutic dose of MitoEVs and/or selectively use fractions that retain mitochondrial functionality.

Degree

thesis:*
Grantor dc:publisher
Institutional Repository of Vilnius University
Year dc:date
2025

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Bikulčiūtė, Barbora,

Rights

dc:rights
Statement dc:rights
  • info:eu-repo/semantics/openAccess
Language dc:language
lit

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
Vilnius University
Base URL
epublications.vu.lt/oai
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Bikulčiūtė, Barbora,. Mezenchiminių kamieninių ląstelių sekretuojamų mitochondrijas turinčių ekstraląstelinių vezikulių poveikio doksorubicino sukeltai AC16 kardiomiocitų hipertrofijai vertinimas /. Institutional Repository of Vilnius University, 2025. https://repository.vu.lt/VU:ELABAETD239024455&prefLang=en_US